Epigenetics

5 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• NCONTACT3 refused lines

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

• NUTRIT LBL3 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

Questions about Epigenetics

Is Epigenetics on an FDA import alert?

No listing for Epigenetics appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the United Kingdom page.

Has FDA refused shipments from Epigenetics?

Yes. FDA refused 3 shipment lines from Epigenetics on October 19, 2016. The most recent, on October 19, 2016, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as NCONTACT (no u.s. adverse event contact on supplement label).

Why did FDA refuse Epigenetics's shipments?

The most frequent charges are NCONTACT (no u.s. adverse event contact on supplement label, 3 lines) and NUTRIT LBL (nutrition information missing from label, 3 lines).

When was Epigenetics last inspected by FDA?

FDA's most recent inspection of Epigenetics with a final classification is dated June 6, 2017 and was classified NAI (No Action Indicated).

What is Epigenetics's FEI number?

Epigenetics's FDA Establishment Identifier (FEI) is 3011154983.